Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03735628
Title An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bayer
Indications

hepatocellular carcinoma

Advanced Solid Tumor

colorectal cancer

lung non-small cell carcinoma

head and neck squamous cell carcinoma

Therapies

Copanlisib + Nivolumab

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.